USFDA makes 2 observations after inspection of Lupin#39;s Goa plant

USFDA makes 2 observations after inspection of Lupin#39;s Goa plant The company has received a communication from the US Food and Drug Administration (USFDA), classifying the inspection conducted at its Goa facility between January 28 to February 8, 2019 as Official Action Indicated (OAI)... The inspection at the Goa facility had closed with two observations, Lupin said in a regulatory filing.
This entry was posted in Global India, Market News, News. Bookmark the permalink.

Comments are closed.